Catney Charles

Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study

Dominique Farge, Séverine Loisel, Matthieu Resche‐Rigon et al. · The Lancet Rheumatology · 2022 · 37 citations · Full text

Medicine, Hematology, Immunology +12

Association of Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis With Marked Improvement in Health‐Related Quality of Life

Nancy Maltez, Mathieu Puyade, Mianbo Wang et al. · Arthritis & Rheumatology · 2020 · 17 citations

Medicine, Immunology, Cell Therapy +13

Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite score

Nassim Ait Abdallah, Mianbo Wang, Pauline Lansiaux et al. · Bone Marrow Transplantation · 2021 · 15 citations

Medicine, Clinical Sciences, Autoimmunity +8

Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study

Dominique Farge, Lucie Biard, Ben Weil et al. · The Lancet Rheumatology · 2024 · 13 citations

Life Sciences, Immunology, Autoimmunity +13